Our first speaker in this webinar, Dr. Jessica Hartman, will discuss the challenges of iPSC reprogramming, including low efficiency, pluripotency instability and high labor intensity. She’ll showcase ...

According to Ding, more systematic techniques are the key to boosting efficiency: “The current iPSC reprogramming process is essentially an undirected, nonspecific process involving so many ...

So, you get more healthy mice by just changing one letter,” he said, Super-SOX also achieved something that the Oct4-free cocktail couldn't: enhanced human iPSC generation. Generating human iPSCs is ...

Traditional methods of converting one type of cell into another require an intermediate step: reprogramming the cell into an induced pluripotent stem cell (iPSC) before differentiating it into the ...

Are we close to generating a bioengineered human heart? Camila Hochman-Mendez weighs in on recent advances and remaining ...

Century Therapeutics (NASDAQ: IPSC) is a clinical-stage biotechnology company leveraging its expertise in cellular reprogramming, genetic engineering, and manufacturing to develop cell therapies ...

iPSC-based models of heart disease are furthest along. Development of treatments, by engineering sheets of heart cells or directly reprogramming other heart cells, is still in the preclinical or ...

However, recreating the pathogenesis of age-dependent conditions such as Parkinson’s Disease (PD) is limited by a rejuvenating effect of the reprogramming process. In fact, our group has recently ...